Ferns et al., 2006 - Google Patents
Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal …Ferns et al., 2006
- Document ID
- 5067396895057685726
- Author
- Ferns R
- Garson J
- Publication year
- Publication venue
- Journal of virological methods
External Links
Snippet
Quantification of cell–free virus in plasma is important for monitoring disease progression and for assessing the response to antiretroviral therapy in both human immunodeficiency type 1 and type 2 (HIV-1, HIV-2) infections. Although commercial assays suitable for HIV-1 …
- 241000713340 Human immunodeficiency virus 2 0 title abstract description 96
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
- C12Q1/6895—Hybridisation probes for detection or identification of organisms for plants, fungi, or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6846—Common amplification features
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Curtis et al. | Rapid detection of HIV-1 by reverse-transcription, loop-mediated isothermal amplification (RT-LAMP) | |
| Kandathil et al. | Molecular epidemiology of HIV | |
| Ferns et al. | Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control | |
| Chang et al. | Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform | |
| US8575324B2 (en) | Methods and reagents for molecular detection of HIV-1 groups M, N and O | |
| Anantharajah et al. | How to choose the right real-time RT-PCR primer sets for the SARS-CoV-2 genome detection? | |
| Rouet et al. | Comparison of the generic HIV viral load® assay with the Amplicor™ HIV-1 monitor v1. 5 and Nuclisens HIV-1 EasyQ® v1. 2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho bora preparatory study | |
| Ruelle et al. | Quantitative real-time PCR on Lightcycler® for the detection of human immunodeficiency virus type 2 (HIV-2) | |
| Kijak et al. | Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v. 2 | |
| van der Sluis et al. | Quantitation of HIV-1 DNA with a sensitive TaqMan assay that has broad subtype specificity | |
| Jacobs et al. | Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa | |
| CN105452487B (en) | Real-time PCR point mutation assay for detecting HIV-1 resistance to antiviral drugs | |
| Delarue et al. | Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection | |
| Aitken et al. | Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes | |
| Yamaguchi et al. | Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates | |
| US9765406B2 (en) | Tools and method for the detection and quantification of genetically diverse HIV-1, SIVcpz and SIV gor viruses | |
| Schvachsa et al. | Examination of real-time PCR for HIV-1 RNA and DNA quantitation in patients infected with HIV-1 BF intersubtype recombinant variants | |
| Troyer et al. | A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother–infant pairs from Uganda | |
| US10385410B2 (en) | In vitro method for the detection and quantification of HIV-2 | |
| Bennett et al. | A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cells | |
| EP1100959B1 (en) | Method and kit for detecting resistance to antiviral drugs | |
| Nolan et al. | Single genome sequencing of expressed and proviral HIV-1 envelope glycoprotein 120 (gp120) and nef Genes | |
| Jacobs et al. | Serotyping and genotyping of HIV‐1 infection in residents of Khayelitsha, Cape Town, South Africa | |
| Brandful et al. | Genotypic diversity and mutation profile of HIV-1 strains in antiretroviral treatment (ART)–Naïve Ghanaian patients and implications for antiretroviral treatment (ART) | |
| Khamadi et al. | HIV type 1 genetic diversity in Moyale, Mandera, and Turkana based on env-C2-V3 sequences |